(Q33730730)

29 July 2017

1 reference

title

Narcolepsy: a key role for hypocretins (orexins) (English)

1 reference

29 July 2017

0 references

Siegel JM

1

1 reference

PubMed ID

10481905

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

29 July 2017

1 reference

29 July 2017

98

1 reference

29 July 2017

409-412

1 reference

29 July 2017

4

1 reference

Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Induction of outward current by orexin-B in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Genetic and familial aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Neurons containing hypocretin (orexin) project to multiple neuronal systems

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Feeding response to central orexins.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Distribution of orexin receptor mRNA in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

Locus coeruleus neurons: cessation of activity during cataplexy.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981969-8

7 January 2021

10.1016/S0092-8674(00)81969-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10481905